Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 6, 2006, Pages 1026-1035

  Kim, Jin C ^a   Kim, Hee C ^a   Lee, Kang H ^a   Yu, Chang S ^a   Kim, Tae W ^a   Chang, Heung M ^a   Ryu, Min H ^a   Kim, Jong H ^a   Ha, Hyun K ^a   Lee, Moon G ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Chemotherapy; Colorectal cancer; Hepatic artery; Liver metastasis; Systemic

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; BILIRUBIN; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CHOLANGITIS; COLITIS; COLORECTAL CANCER; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; FEMALE; GASTRITIS; GASTROINTESTINAL TOXICITY; HAND FOOT SYNDROME; HEADACHE; HEMATOLOGIC DISEASE; HEPATITIS; HUMAN; LEUKOPENIA; LIVER CIRCULATION; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROPATHY; PIGMENT DISORDER; PRIORITY JOURNAL; PRURITUS; SCLEROSING CHOLANGITIS; SKIN DISEASE; STOMATITIS; SURVIVAL TIME; THORAX PAIN; THROMBOCYTOPENIA; TOXIC HEPATITIS; VOMITING;

EID: 33744776644     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.04023.x     Document Type: Article

References (33)

1. Russell AH, Tong D, Dawson LE, Wisbeck W. Adenocarcinoma of the proximal colon. Sites of initial dissemination and patterns of recurrence following surgery alone. Cancer 1984 53:360 67.
2. Dizon DS, Kemeny NE. Intrahepatic arterial infusion of chemotherapy: clinical results. Semin. Oncol. 2002 29:126 35.
3. Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg. Oncol. Clin. N. Am. 2003 12:165 92.
4. Fong Y, Cohen AM, Fortner JG et al. Liver resection for colorectal metastases. J. Clin. Oncol. 1997 15:938 46.
5. Lehnert T, Otto G, Herfarth C. Therapeutic modalities and prognostic factors for primary and secondary liver tumors. World J. Surg. 1995 19:252 63.
6. Zelek L, Bugat R, Cherqui D et al. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). Ann. Oncol. 2003 14:1537 42.
7. Archer SG, Gray BN. Vascularization of small liver metastases. Br. J. Surg. 1989 76:545 8.
8. Kemeny M. Hepatic artery infusion of chemotherapy as a treatment for hepatic metastases from colorectal cancer. Cancer J. 2002 8 Suppl. 1 82 8.
9. van Riel JM, van Groeningen CJ, Albers SH et al. Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: single-centre experience in 145 patients. Ann. Oncol. 2000 11:1563 70.
10. Kerr DJ, McArdle CS, Ledermann J et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 2003 361:368 73.
11. Lorenz M, Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J. Clin. Oncol. 2000 18:243 54.
12. Howell JD, McArdle CS, Kerr DJ et al. A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases. Br. J. Cancer 1997 76:1390 93.
13. Kemeny N, Huang Y, Cohen AM et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N. Engl. J. Med. 1999 341:2039 48.
14. Saltz LB, Cox JV, Blanke C et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N. Engl. J. Med. 2000 343:905 14.
15. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J. Natl. Cancer Inst. 1996 88:252 8.
16. O'Connell MJ, Nagorney DM, Bernath AM et al. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. J. Clin. Oncol. 1998 16:2528 33.
17. Link KH, Sunelaitis E, Kornmann M et al. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival. Cancer 2001 92:2746 53.
18. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981 47:207 14.
19. Rougier P, Laplanche A, Huguier M et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J. Clin. Oncol. 1992 10:1112 18.
20. Ross P, Norman A, Cunningham D et al. A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann. Oncol. 1997 8:995 1001.
21. Kemeny MM, Adak S, Gray B et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J. Clin. Oncol. 2002 20:1499 505.
22. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Nakajima N. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases. Br. J. Surg. 1999 86:1025 31.
23. Sadahiro S, Suzuki T, Tokunaga N, Tajima T, Makuuchi H, Ohtaki M. Prevention of hepatic artery occlusion during continuous infusion of fluorouracil using liposteroid. Am. J. Roentgenol. 2000 175:1641 2.
24. Durand-Zaleski I, Roche B, Buyse M et al. Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases. Meta-Analysis Group In Cancer. Crit. Rev. Oncol. Hematol. 1999 32:125 31.
25. Fallik D, Ychou M, Jacob J et al. Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer. Ann. Oncol. 2003 14:856 63.
26. Laurent CSa, Cunha A, Couderc P, Rullier E, Saric J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br. J. Surg. 2003 90:1131 6.
27. Pettavel J, Gardiol D, Bergier N et al. Necrosis of main bile ducts caused by hepatic artery infusion of 5-fluoro-2-deoxyuridine. Reg Cancer Treat 1988 1:83 92.
28. Hosokawa A, Yamada Y, Shimada Y et al. Weekly hepatic arterial infusion of 5-fluorouracil and subsequent systemic chemotherapy for liver metastases from colorectal cancer. Jpn. J. Clin. Oncol. 2003 33:132 5.
29. Allendorf JD, Bessler M, Kayton ML et al. Increased tumor establishment and growth after laparotomy vs laparoscopy in a murine model. Arch. Surg. 1995 130:649 53.
30. Kwon AH, Matsui Y, Kamiyama Y. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer 2001 91:771 8.
31. Gonen M, Hummer A, Zervoudakis A et al. Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J. Clin. Oncol. 2003 21:406 12.
32. Khan ZA, Jonas SK, Feldmann KA et al. P53 mutation and response to hepatic arterial floxuridine in patients with colorectal liver metastases. J. Cancer Res. Clin. Oncol. 2001 127:675 80.
33. Nelson RL, Freels S. A systematic review of hepatic artery chemotherapy after hepatic resection of colorectal cancer metastatic to the liver. Dis. Colon Rectum 2004 47:739 45.